Establishment Labs Reports Strong Q3 2026 Growth and First Positive Free Cash Flow
Establishment Labs (ESTA) reported significant third-quarter growth, with total revenue rising 33.9% year-over-year to $72.0 million. This performance was primarily driven by a massive 119% surge in U.S. revenue and the rapid expansion of its minimally invasive platform, which grew 124% year-over-year. Notably, the company achieved its first quarter of positive free cash flow in history, reaching $5.1 million. Following these results, management raised its full-year 2026 revenue guidance to over $274 million. While geopolitical tensions in the Middle East have impacted regional order levels and a higher mix of distributor sales slightly moderated gross margins, the company's U.S. market share in augmentation has reached an estimated 30%. Looking ahead, the company is focusing on increasing surgeon training and preparing for upcoming product launches in breast reconstruction.
Tickers: $ESTA
Topics: free cash flow guidance raise market share expansion revenue growth
Read the full article at Motley Fool
Part of the story DeFi Technologies Schedules Shareholder Call for Q3 2026 Financial Results (51 articles)